Caudal Dexamethasone - Bupivacaine in Neonates

N/ANot Yet RecruitingNCT07609836

Ain Shams University150 enrolled

Overview

Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates

Evaluate the additive analgesic effects of caudal Dexamethasone in neonates undergoing inguinal hernia repair. additive side effects if found

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

150

Conditions

We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

Interventions

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine groupPROCEDURE

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonates undergoing inguinal hernia repair

Eligibility

Sex: ALLMin age: 1 DayMax age: 28 Days

Medical Language ↔ Plain English

Inclusion Criteria: * full term neonate * ASA I \& ASA II * Scheduled for inguinal hernia repair Exclusion Criteria: * Patients with allergies to studied drugs * body weight \<3 kilograms * parents refusal

Outcomes

Primary Outcomes

FLACC pain scale (face,leg , activity,cry, consolability) in the first 24 hours postoperative

Assessment for additive analgesic effects of caudal Dexamethasone

Time frame: 6 months

Central Contacts

Sawsan Haridy Ahmed Abu El Hassan, Lecturer of anesthesia

CONTACT

002- 01228118341 sawsan_haridy@med.asu.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.